PRODUCT DETAIL

Erlotinib STADA 100 mg

Code

3499D

MA number

44/0211/17-S

Product Form:

tbl flm 90x1x100 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

44 - CYTOSTATICA

ATC:

L	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01	ANTINEOPLASTIC AGENTS
L01E	Protein kinase inhibitors
L01EB	Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors
L01EB02	Erlotinib

Shelf life:

Container:

blister Al/OPA/Al/PVC

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to restricted medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	19.07.2017
PIL:	PIL_Erlotinib STADA 100 mg_05.2023.pdf
SPC:	SPC_Erlotinib STADA 100 mg_09.2023.pdf
Safety feature	Yes
Data update:	07.09.2023